Advances in toxicological research of the anticancer drug cisplatin

L Qi, Q Luo, Y Zhang, F Jia, Y Zhao… - Chemical research in …, 2019 - ACS Publications
Cisplatin is one of the most widely used chemotherapeutic agents for various solid tumors in
the clinic due to its high efficacy and broad spectrum. The antineoplastic activity of cisplatin …

Adjuvant role of Salvia miltiorrhiza bunge in cancer chemotherapy: A review of its bioactive components, health-promotion effect and mechanisms

J Huang, J Zhang, C Sun, R Yang, M Sheng… - Journal of …, 2024 - Elsevier
Ethnopharmacological relevance Chemotherapy is a common cancer treatment strategy.
However, its effectiveness is constrained by toxicity and adverse effects. The Lamiaceae …

Mechanisms of cisplatin-induced ototoxicity and prevention

LP Rybak, D Mukherjea, V Ramkumar - Seminars in hearing, 2019 - thieme-connect.com
Cisplatin is a highly effective antineoplastic agent used to treat solid tumors. Unfortunately,
the administration of this drug leads to significant side effects, including ototoxicity …

Promising hepatoprotective effects of lycopene in different liver diseases

IM Ibrahim, HS Althagafy, EK Abd-Alhameed… - Life Sciences, 2022 - Elsevier
The incidence of liver diseases such as hepatitis, fibrosis, cirrhosis, and liver cancer is one
of the world's most significant health challenges. Liver diseases can be caused by a variety …

The genetic vulnerability to cisplatin ototoxicity: a systematic review

E Tserga, T Nandwani, NK Edvall, J Bulla, P Patel… - Scientific reports, 2019 - nature.com
Ototoxicity is one of the major side-effects of platinum-based chemotherapy, in particular
cisplatin (cis-diammine dichloroplatinum II). To our knowledge, no systematic review has …

Pharmacogenetics of drug-induced ototoxicity caused by aminoglycosides and cisplatin

C Lanvers-Kaminsky, G Ciarimboli - Pharmacogenomics, 2017 - Taylor & Francis
Aminoglycosides and the anticancer drug cisplatin can cause permanent hearing loss,
which impacts patients' quality of life and results in considerable subsequent costs. Since …

Predictors of cisplatin-induced ototoxicity and survival in chemoradiation treated head and neck cancer patients

WA Teft, E Winquist, AC Nichols, S Kuruvilla, S Richter… - Oral Oncology, 2019 - Elsevier
Objectives Cisplatin-induced ototoxicity is a common permanent consequence of curative
chemoradiation for locally advanced head and neck squamous cell carcinoma (HNSCC) …

Hyperin protects against cisplatin-induced liver injury in mice

C Niu, M Ma, X Han, Z Wang, H Li - Acta cirurgica brasileira, 2017 - SciELO Brasil
Purpose: To evaluate the effect of hyperin in cisplatin-induced liver injury in mice. Methods:
Mice were pretreated with hyperin at doses of 25 mg/kg and 50 mg/kg, respectively, for six …

Pharmacogenomics of cisplatin‐induced ototoxicity: successes, shortcomings, and future avenues of research

BI Drögemöller, GEB Wright, C Lo, T Le… - Clinical …, 2019 - Wiley Online Library
Cisplatin is a highly effective chemotherapeutic. Unfortunately, its use is limited by cisplatin‐
induced ototoxicity (CIO). Substantial research has been performed to uncover the genetic …

Monitoring protocols for cochlear toxicity

SG Lord - Seminars in hearing, 2019 - thieme-connect.com
The need for monitoring hearing and auditory function during drug therapy and other
treatments that have the potential to cause hearing loss is well documented. Besides the …